CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...
Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...
We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look ...
A giant healthcare company is suing the State of Minnesota over a state law that is supposed to protect small pharmacies in ...
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
Investors in CVS Health Corp. (NYSE: CVS) will be looking for signs of improvement when the company's fourth-quarter and full-year earnings are released Wednesday morning ahead of the opening bell.
We recently compiled a list of the Jim Cramer Recently Talked About These 11 S&P 500 Stocks. In this article, we are going to ...
Elevance Health is the only health insurance company of 10 Moody's Ratings evaluated that received a "positive" credit ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...
Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.
Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results